Annual Shareholders Equity
$183.11 M
-$40.69 M-18.18%
December 31, 2022
Summary
- As of February 10, 2025, JNCE annual stockholders equity is $183.11 million, with the most recent change of -$40.69 million (-18.18%) on December 31, 2022.
- During the last 3 years, JNCE annual shareholders equity has risen by +$8.52 million (+4.88%).
Performance
JNCE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$183.11 M
+$53.75 M+41.55%
December 31, 2022
Summary
- As of February 10, 2025, JNCE quarterly stockholders equity is $183.11 million, with the most recent change of +$53.75 million (+41.55%) on December 31, 2022.
- Over the past year, JNCE quarterly shareholders equity has dropped by -$40.69 million (-18.18%).
Performance
JNCE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
JNCE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.2% | -18.2% |
| 3 y3 years | +4.9% | +4.9% |
| 5 y5 years | +9.6% | +9.6% |
JNCE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.2% | at low | -18.2% | -29.4% |
| 5 y | 5-year | -18.2% | -4.7% | -34.5% | -42.6% |
| alltime | all time | -18.2% | -100.3% | -34.5% | -75.5% |
Jounce Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $183.11 M(-18.2%) | $183.11 M(+41.6%) |
| Sep 2022 | - | $129.36 M(-18.0%) |
| Jun 2022 | - | $157.73 M(-16.5%) |
| Mar 2022 | - | $188.96 M(-15.6%) |
| Dec 2021 | $223.81 M(+5.9%) | $223.81 M(-11.0%) |
| Sep 2021 | - | $251.37 M(-9.7%) |
| Jun 2021 | - | $278.46 M(-0.4%) |
| Mar 2021 | - | $279.45 M(+32.3%) |
| Dec 2020 | $211.29 M(+21.0%) | $211.29 M(+101.1%) |
| Sep 2020 | - | $105.09 M(-17.4%) |
| Jun 2020 | - | $127.27 M(-16.6%) |
| Mar 2020 | - | $152.54 M(-12.6%) |
| Dec 2019 | $174.59 M | $174.59 M(-8.8%) |
| Sep 2019 | - | $191.41 M(+112.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $90.06 M(-4.6%) |
| Mar 2019 | - | $94.42 M(-9.3%) |
| Dec 2018 | $104.13 M(-37.7%) | $104.13 M(+0.7%) |
| Sep 2018 | - | $103.41 M(-4.7%) |
| Jun 2018 | - | $108.50 M(-1.6%) |
| Mar 2018 | - | $110.29 M(-34.0%) |
| Dec 2017 | $167.11 M(+132.5%) | $167.11 M(-4.5%) |
| Sep 2017 | - | $175.06 M(-1.5%) |
| Jun 2017 | - | $177.70 M(-1.4%) |
| Mar 2017 | - | $180.15 M(+150.7%) |
| Dec 2016 | $71.87 M(+60.2%) | $71.87 M(+9.8%) |
| Sep 2016 | - | $65.45 M(+45.9%) |
| Dec 2015 | $44.86 M(-8484.3%) | $44.86 M |
| Dec 2014 | -$535.00 K | - |
FAQ
- What is Jounce Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Jounce Therapeutics?
- What is Jounce Therapeutics annual shareholders equity year-on-year change?
- What is Jounce Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Jounce Therapeutics?
- What is Jounce Therapeutics quarterly shareholders equity year-on-year change?
What is Jounce Therapeutics annual stockholders equity?
The current annual shareholders equity of JNCE is $183.11 M
What is the all time high annual shareholders equity for Jounce Therapeutics?
Jounce Therapeutics all-time high annual stockholders equity is $223.81 M
What is Jounce Therapeutics annual shareholders equity year-on-year change?
Over the past year, JNCE annual stockholders equity has changed by -$40.69 M (-18.18%)
What is Jounce Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of JNCE is $183.11 M
What is the all time high quarterly shareholders equity for Jounce Therapeutics?
Jounce Therapeutics all-time high quarterly stockholders equity is $279.45 M
What is Jounce Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, JNCE quarterly stockholders equity has changed by -$40.69 M (-18.18%)